Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors

Journal of Clinical Oncology

Volumn 18, Issue 5, 2000, Pages 1020-1026

  Warren, Katherine E ^a   Frank, Joseph A ^a   Black, Jeanette L ^a   Hill, Rene S ^a   Duyn, Josef H ^a   Aikin, Alberta A ^a   Lewis, Bobbi K ^a   Adamson, Peter C ^a   Balis, Frank M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SCHOOL CHILD; TUMOR DIAGNOSIS;

EID: 0033995248     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.5.1020     Document Type: Article

References (35)

1. Surveillance, Epidemiology, and End-Results (SEER): SEER Cancer Statistics Review, 1973-1996: Childhood Cancer by the ICCC, 1999. Bethesda, MD, NIH publication, 1999
2. Campbell J, Pollack IF, Martinez AJ, et al: High grade astrocytomas in children: Radiologically complete resection is associated with an excellent long-term prognosis. Neurosurg 38:258-264, 1996
3. Duffner PK, Krischer JP, Sanford RA, et al: Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 28:215-222, 1998
4. Giordana MT, Schiffer P, Schiffer D: Prognostic factors in medulloblastoma. Childs Nerv Syst 14:256-262, 1998
5. Packer RJ: Brain tumors in children. Curr Opin Pediatr 8:549-557, 1996
6. Zeltzer PM, Boyett JM, Finlay JL, et al: Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III trial. J Clin Oncol 17:832-845, 1999
7. Moonen CT, van Zijl PCM, Frank JA, et al: Functional magnetic resonance imaging in medicine and physiology. Science 50:53-61, 1990
8. 1H NMR spectra of metabolites in the human brain. Proc Natl Acad Sci USA 85:1821-1825, 1988
9. Frahm J, Bruhn H, Gyngell ML, et al: Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo. Magn Reson Med 9:79-93, 1989
10. Tzika AA, Vajapeyam S, Barnes PD: Multivoxel proton MR spectroscopy and hemodynamic MR imaging of childhood brain tumors: Preliminary observations. Am J Neuroradiol 18:203-218, 1997
11. 1H MR spectroscopy in vivo: Initial experience in patients with cerebral tumors. Radiology 172:541-548, 1989
12. Brunetti A, Alfano B, Soricelli A, et al: Functional characterization of brain tumors: An overview of the potential clinical value. Nuclear Med Biol 23:699-715, 1996
13. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann Neurol 31:202-211, 1992
14. Kruse B, Barker PB, van Zijl PCM, et al: Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 36:595-608, 1994
15. 18F fluorodeoxyglucose PET. Radiology 177:633-641, 1990
16. Fulham MJ, Bizzi A, Dietz MJ, et al: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185:675-686, 1992
17. Taylor JS, Ogg RJ, Langston JW: Proton MR spectroscopy of pediatric brain tumors. Neuroimaging Clin N Am 8:753-779, 1998
18. Ross B, Michaelis T: Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 10:191-247, 1994
19. Tate AR, Griffiths JR, Martinez-Perez I, et al: Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed 11:177-191, 1998
20. Preul MC, Caramanos Z, Collins DL, et al: Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325, 1996
21. Tedeschi G, Lundbom N, Raman R, et al: Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516-524, 1997
22. Duyn JH, Gillen J, Sobering G, et al: Multisection proton MR spectroscopic imaging of the brain. Radiology 188:277-282, 1993
23. Novotny E, Ashwal S, Shevell M: Proton magnetic resonance spectroscopy: An emerging technology in pediatric neurology research. Pediatr Res 44:1-10, 1998
24. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1963
25. 1H-MRS using water as an internal standard. Magn Reson Imaging 11:107-118, 1993
26. Byrd SE, Tomita T, Palka PS, et al: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, part I: Introduction to MRS. J Natl Med Assoc 88:649-654, 1996
27. Sober BJ, van Zijl PC, Duyn JH, et al: Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 35:356-363, 1996
28. Tedeschi G, Bertolino A, Righini A, et al: Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 45:1384-1391, 1995
29. Lazareff JA, Olmstead C, Bockhorst KH, et al: Proton magnetic resonance spectroscopic imaging of pediatric low-grade astrocytomas. Childs Nerv Syst 12:130-135, 1996
30. 1H NMR spectroscopy: N-acetyl-aspartate, creatine and choline. NMR Biomed 4:47-52, 1991
31. 1H-NMR spectroscopic studies of the brain. Neurosci Biobehav Rev 13:23-31, 1989
32. Byrd SE, Tomita T, Palka PS, et al: Magnetic resonance spectroscopy (MRS) in the evaluation of pediatric brain tumors, part II: Clinical analysis. J Natl Med Assoc 88:717-723, 1996
33. Sutton LN, Wang Z, Gusnard D, et al: Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurg 31:195-202, 1992
34. Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458, 1996
35. Taylor JS, Langston JW, Reddick WE, et al: Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 36:1251-1261, 1996